Back to Results
First PageMeta Content



SUPPLEMENT ARTICLE Models of Care for the Management of Hepatitis C Virus Among People Who Inject Drugs: One Size Does Not Fit All Philip Bruggmann1 and Alain H. Litwin2
Add to Reading List

Document Date: 2014-07-10 03:28:20


Open Document

File Size: 102,49 KB

Share Result on Facebook

City

Worcester / New York / Zurich / Vancouver / Amsterdam / London / /

Company

Kadmon Pharmaceuticals / Strathdee SA / Thomson / Oxford University Press / Merck / Gilead Sciences / Vertex / /

Country

Switzerland / United States / Canada / Australia / United Kingdom / Scotland / /

/

Facility

C clinic / University of New South Wales / The Kirby Institute / Montefiore Medical Center / Arch Gen Psychiatry / Meyers Primary Care Institute / Albert Einstein College of Medicine / /

IndustryTerm

care for patients with serious psychiatric illness / HCV therapy / addiction services / psychiatric services / alcohol support services / health services / access healthcare services / therapy for hepatitis C / social support services / community-based health services / treatment of HCV / HCV care / viral hepatitis services / treatment services / telehealth technology / healthcare system / HCV therapies / hepatitis C care / multidisciplinary health services / HCV treatment / as HCV treatment / treatment for hepatitis C / hepatitis C treatment / /

MedicalCondition

Notes disease / chronic illnesses / HIV / substance use disorder / Kumar MS. Hepatitis C / hepatitis C / hepatitis B / successful chronic hepatitis C / HIV infections / HCV genotype 3 / hepatitis / different hepatitis C / MS / infections / HCVrelated liver disease / successfully administered hepatitis C / heroin users / Nygaard E. Hepatitis C / disease / Bruggmann P. Hepatitis C / AIDS Patient Care STDS / HCV-induced disease / both hepatitis C / HCV / serious psychiatric illness / Bruggmann P. Accessing hepatitis C / HCV infection / virus infection / drug abuse / sexually transmitted infections / AIDS / infectious diseases / HIV/AIDS / crack cocaine users / future disease / infection / viral hepatitis / chronic hepatitis / et al. Hepatitis C / chronic hepatitis C / tuberculosis / /

MedicalTreatment

antiretroviral therapy / counseling / antiviral therapy / directly observed therapy / /

Organization

Kirby Institute / influences / University of New South Wales / Infectious Diseases Society of America / Department of Medicine / Albert Einstein College of Medicine / Montefiore Medical Center / ore Medical Center / Oxford University / Meyers Primary Care Institute / /

Person

Jules Levin / Bradley P. Hepatitis / Philip Bruggmann / /

Position

general practitioner / psychiatrist / advisor / specialized nurse and a psychiatrist / model in the United Kingdom / drug worker / speaker / clinical specialist psychiatric nurse / internal medicine specialist / a psychiatrist / consultant / General / Author / innovative model of group / model of HCV management / clinical nurse specialist / specialist nurse / nurse / Agenda Forward / internist addiction medicine specialist / /

Product

Peginterferon / ribavirin / PEGASYS / /

ProgrammingLanguage

J / /

ProvinceOrState

New York / New South Wales / Massachusetts / /

PublishedMedium

Clinical Infectious Diseases / /

Region

South Wales / /

Technology

alpha / GPS / telehealth technology / genotype / /

URL

http /